Kristin joined Royalty Pharma in 2016. Previously, Kristin was a director at Ernst & Young LLP Capital Markets in London, specializing in US transactions involving European life sciences companies. Kristin also previously managed the external SEC reporting for iHeartMedia and was an auditor at Deloitte. Kristin has a BA, with honors, from Sonoma State University.
